As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged. Synpromics is pleased to invite you to join them for a special symposium during the ASGCT Annual Meeting which will include presentations from Synpromics’ partners, an interactive panel discussion, and will be followed by a networking reception and refreshments. Please see the full agenda below.
Synpromics Scientific Symposium: Next Generation Gene Medicine – Leveraging synthetic promoters in product design
Wednesday May 16, 2018
720 South Michigan Avenue
Interested in Attending?
This meeting is open to all ASGCT Attendees.
Welcome Remarks - David Venables, PhD, Chief Executive Officer, Synpromics
Introduction - Symposium/Panelists - Sarah Haecker Meeks, PhD, Vice President, Business Development, Synpromics
Michael Roberts, PhD, Chief Scientific Officer, Founder, Synpromics
Joel Schneider, PhD, Chief Technology Officer, Solid Biosciences
Jude Samulski, PhD, Founder, AskBIO
Francois Du Plessis, Scientist - Vector Development, uniQure
Albert Seymour, PhD, Chief Scientific Officer, Homology Medicines
Mark S. Shearman, PhD, Chief Scientific Officer, Applied Genetic Technologies Corporation
Panel Discussion - Moderated by Sarah Haecker Meeks, PhD
Networking Reception - with drinks and hors d'oeurves